Quarterly report pursuant to Section 13 or 15(d)

Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details)

v3.23.2
Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net loss available to stockholders $ (780,110) $ (856,218) $ (2,270,139) $ (766,809)
Weighted average shares outstanding - basic 24,850,261 24,850,261 24,850,261 24,850,261
Effect of dilutive securities:        
Weighted average shares outstanding - Diluted 24,850,261 24,850,261 24,850,261 24,850,261
Net income (loss) per share - basic (in USD per share) $ (0.03) $ (0.03) $ (0.09) $ (0.03)
Net income (loss) per share - diluted (in usd per share) $ (0.03) $ (0.03) $ (0.09) $ (0.03)
Stock Options        
Effect of dilutive securities:        
Stock options 0 0 0 0
Anti-dilutive shares underlying stock options outstanding 1,831,851 925,396 1,831,851 925,396